Treatment of diffuse diabetic macular oedema: a comparison between argon and krypton lasers.
We report the results of a randomised treatment trial of macular grid photocoagulation in 91 eyes with diffuse diabetic macular oedema followed up for at least two years comparing Krypton red with Argon blue/green lasers. At two years, macular oedema had improved equally in both groups, and the visual acuity was unchanged or better in 85% of eyes treated with Argon and in 79.5% of eyes treated with Krypton laser. No statistically significant differences were observed between the two groups in terms of visual acuity or the degree of oedema. We conclude that the observed effect of grid laser treatment in diffuse diabetic macular oedema did not depend on the wavelength of the laser light used in this study.
Casswell
A G
AG
Moorfields Eye Hospital, London.
Canning
C R
CR
Gregor
Z J
ZJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001128:Argon; D003930:Diabetic Retinopathy / Q000601:surgery*; D005260:Female; D006801:Humans; D007726:Krypton; D008028:Light Coagulation; D008268:Macular Degeneration / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014792:Visual Acuity
D007726:Krypton; D001128:Argon